These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38677331)

  • 1. Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice.
    Buzzi B; AlSharari SD; Walentiny DM; Damaj MI
    Behav Brain Res; 2024 Jun; 467():115019. PubMed ID: 38677331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice.
    Bagdas D; Alkhlaif Y; Jackson A; Carroll FI; Ditre JW; Damaj MI
    Neuropharmacology; 2018 Aug; 138():72-79. PubMed ID: 29860196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice.
    Bagdas D; Muldoon PP; Zhu AZ; Tyndale RF; Damaj MI
    Neuropharmacology; 2014 Oct; 85():67-72. PubMed ID: 24859605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse.
    Jackson KJ; Carroll FI; Negus SS; Damaj MI
    Psychopharmacology (Berl); 2010 Jun; 210(2):285-94. PubMed ID: 20232057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The β3 subunit of the nicotinic acetylcholine receptor is required for nicotine withdrawal-induced affective but not physical signs or nicotine reward in mice.
    Jackson AB; Toma W; Contreras KM; Alkhlaif Y; Damaj MI
    Pharmacol Biochem Behav; 2019 Aug; 183():1-5. PubMed ID: 31145916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of orally-bioavailable short-acting kappa opioid receptor-selective antagonist LY2456302 on nicotine withdrawal in mice.
    Jackson KJ; Jackson A; Carroll FI; Damaj MI
    Neuropharmacology; 2015 Oct; 97():270-4. PubMed ID: 26044637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hydroxymetabolites of bupropion on nicotine dependence behavior in mice.
    Damaj MI; Grabus SD; Navarro HA; Vann RE; Warner JA; King LS; Wiley JL; Blough BE; Lukas RJ; Carroll FI
    J Pharmacol Exp Ther; 2010 Sep; 334(3):1087-95. PubMed ID: 20576796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetylcysteine decreased nicotine reward-like properties and withdrawal in mice.
    Bowers MS; Jackson A; Maldoon PP; Damaj MI
    Psychopharmacology (Berl); 2016 Mar; 233(6):995-1003. PubMed ID: 26676982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations.
    Varani AP; Aso E; Moutinho LM; Maldonado R; Balerio GN
    Psychopharmacology (Berl); 2014 Aug; 231(15):3031-40. PubMed ID: 24553576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.
    Jackson A; Bagdas D; Muldoon PP; Lichtman AH; Carroll FI; Greenwald M; Miles MF; Damaj MI
    Neuropharmacology; 2017 May; 118():38-45. PubMed ID: 28279662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central histaminergic transmission modulates the expression of chronic nicotine withdrawal induced anxiety-like and somatic behavior in mice.
    Patel D; Vishwakarma PK; Patel R; Jain NS
    Behav Brain Res; 2021 Feb; 399():112997. PubMed ID: 33166570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent differences in nicotine reward and withdrawal in female mice.
    Kota D; Martin BR; Damaj MI
    Psychopharmacology (Berl); 2008 Jun; 198(2):201-10. PubMed ID: 18338157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse agonists of the 5-HT
    Malin D; Henceroth M; Rao GS; Campbell J; Ma JN; Tsai PH; Kishbaugh JC; Burstein ES
    Neurosci Lett; 2019 Nov; 713():134524. PubMed ID: 31585211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal.
    Jackson KJ; McIntosh JM; Brunzell DH; Sanjakdar SS; Damaj MI
    J Pharmacol Exp Ther; 2009 Nov; 331(2):547-54. PubMed ID: 19644040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-oleoyl alanine attenuates nicotine reward and spontaneous nicotine withdrawal in mice.
    Karin KN; Mustafa MA; Poklis JL; Buzzi B; Schlosburg JE; Parker L; Damaj MI; Lichtman AH
    Drug Alcohol Depend; 2024 Jun; 259():111276. PubMed ID: 38676968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats.
    Bruijnzeel AW; Bishnoi M; van Tuijl IA; Keijzers KF; Yavarovich KR; Pasek TM; Ford J; Alexander JC; Yamada H
    Psychopharmacology (Berl); 2010 Dec; 212(4):485-99. PubMed ID: 20697697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice.
    Muldoon PP; Akinola LS; Schlosburg JE; Lichtman AH; Sim-Selley LJ; Mahadevan A; Cravatt BF; Damaj MI
    Neuropharmacology; 2020 Oct; 176():108170. PubMed ID: 32479813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-theanine attenuates nicotine reward and withdrawal signs in mice.
    Alkhlaif Y; El-Halawany M; Toma W; Park A; Hamouda AK; Damaj MI
    Neurosci Lett; 2023 Jun; 807():137279. PubMed ID: 37105354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal.
    Jackson A; Papke RL; Damaj MI
    Psychopharmacology (Berl); 2018 Jul; 235(7):1897-1905. PubMed ID: 29549391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal.
    Zaniewska M; McCreary AC; Wydra K; Filip M
    Neuropharmacology; 2010 Jun; 58(7):1140-6. PubMed ID: 20153341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.